Gilead has yet another reason to justify the high cost of its hepatitis C drug Sovaldi. A clinical study shows that the drug can potentially cure HCV in patients infected with HIV.
Gilead has yet another reason to justify the high cost of its hepatitis C drug Sovaldi. A clinical study shows that the drug can potentially cure HCV in patients infected with HIV.